Dr. Allison Rosenthal is a hematologist-oncologist specializing in lymphoma and an Associate Professor at Mayo Clinic, where she leads clinical and programmatic initiatives focused on improving care for adolescent and young adult (AYA) patients with cancer. Her work centers on optimizing treatment strategies across the lymphoma spectrum. She has a strong interest in clinical decision-making at the intersection of disease biology, patient experience, and long-term outcomes. She has contributed to research and education on evolving frontline and relapsed treatment approaches in lymphoma, including the integration of novel targeted therapies. In parallel, she has developed innovative care models to address gaps in access, survivorship, and supportive care for AYA's with cancer. She brings a patient-centered and evidence-based approach to the debate on observation in newly diagnosed follicular lymphoma, emphasizing the importance of individualized care in an era of expanding therapeutic options.